Labo EuromedisXPAR:ALEMG 61 Quick Ratio is 2.46 as of Dec. 2025, which is 2% above its 10-year median of 2.41. GuruFocus rates XPAR:ALEMG with a GF Score™ of 61/100 and a GF Value™ of €4.48 (Fairly Valued). The stock has 6 warning signs investors should review. Among 118 Medical Distribution companies, Labo Euromedis ranks better than 88.98% on this metric.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. It is calculated as a company's Total Current Assets excludes Total Inventories divides by its Total Current Liabilities. Labo Euromedis's quick ratio for the quarter that ended in Dec. 2025 was 2.46.
Labo Euromedis has a quick ratio of 2.46. It generally indicates good short-term financial strength.
The historical rank and industry rank for Labo Euromedis's Quick Ratio or its related term are showing as below:
XPAR:ALEMG'
s Quick Ratio Range Over the Past 10 Years
Min: 0.79 Med: 2.41 Max: 4.12
Current: 2.46
During the past 13 years, Labo Euromedis's highest Quick Ratio was 4.12. The lowest was 0.79. And the median was 2.41.
XPAR:ALEMG's Quick Ratio is ranked better than 88.98% of 118
companies
in the Medical Distribution industry
Industry Median: 1.05
vs XPAR:ALEMG: 2.46
Labo Euromedis (XPAR:ALEMG) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Labo Euromedis Quick Ratio Related Terms
Labo Euromedis Quick Ratio Historical Data
* Premium members only.
The historical data trend for Labo Euromedis's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XPAR:ALEMG vs MCK, CAH, COR: Quick Ratio Comparison
For the Medical Distribution subindustry, Labo Euromedis's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Labo Euromedis Quick Ratio vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Labo Euromedis's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Labo Euromedis's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Labo Euromedis's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Labo Euromedis (XPAR:ALEMG) has a Quick Ratio of 2.46 as of Dec. 2025. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Labo Euromedis and its competitors. This is near median its historical median of 2.41. Over the past decade, Labo Euromedis' Quick Ratio has ranged from 0.79 to 4.12. According to the industry distribution chart, Labo Euromedis ranks #13 out of 118 companies in the Medical Distribution industry, placing it in the top 11%.
Is Labo Euromedis' Quick Ratio too high?
Labo Euromedis' current Quick Ratio of 2.46 is near median its 10-year median of 2.41. Over the past 10 years, this metric has ranged from a low of 0.79 to a high of 4.12. The Medical Distribution industry median Quick Ratio is 1.05. Labo Euromedis' value of 2.46 is 134.3% above this industry median. Based on the distribution chart, Labo Euromedis ranks #13 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, Labo Euromedis has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Labo Euromedis' Quick Ratio compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Labo Euromedis ranks #13 out of 118 companies for Quick Ratio. This places Labo Euromedis in the top 11% of its industry — outperforming the majority of peers. The industry median Quick Ratio is 1.05. Labo Euromedis' value of 2.46 is 134.3% above this benchmark. Historically, Labo Euromedis' own Quick Ratio has ranged from 0.79 to 4.12 over the past decade. While the company's 10-year median is 2.41 vs. the industry median of 1.05, Labo Euromedis has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Distribution company?
The median Quick Ratio among Medical Distribution companies is 1.05, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Labo Euromedis's current Quick Ratio of 2.46 is 134.3% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Labo Euromedis and its competitors. For the Medical Distribution industry, the median Quick Ratio is 1.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Labo Euromedis's current Quick Ratio is 2.46, which is near median its own 10-year median of 2.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Labo Euromedis stock overvalued right now?
Based on GuruFocus' analysis, Labo Euromedis (XPAR:ALEMG) is currently considered Fairly Valued. The stock's GF Value™ is €4.48, compared to a current price of €4.88 — trading 8.9% above its estimated fair value. The current Quick Ratio is 2.46, which is near median its 10-year median of 2.41 and 134.3% above the Medical Distribution industry median of 1.05. Labo Euromedis' overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Labo Euromedis (XPAR:ALEMG), the current Quick Ratio is 2.46 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Labo Euromedis (XPAR:ALEMG) Overvalued in 2026?
Based on GuruFocus' analysis, Labo Euromedis stock appears to be overvalued.
The current stock price of €4.88 is trading 8.9% above its estimated GF Value™ of €4.48.
GuruFocus considers Labo Euromedis to be Fairly Valued.
Key valuation signals for XPAR:ALEMG:
Quick Ratio: 2.46 (near median its 10-year median of 2.41)
GF Value™: €4.48 vs. price of €4.88 (8.9% above fair value)
Industry Position: 134.3% above the Medical Distribution median (#13 of 118)
No single metric tells the full story. See the XPAR:ALEMG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Labo Euromedis is engaged in medical devices. It is engaged in the design, manufacture, rental and export of medical and surgical equipment and products.
61GF Score
Get the complete analysis for XPAR:ALEMG
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XPAR:ALEMG has been successfully added to your 
